TAMPA, Fla., Oct. 10, 2016 -- The Eye Doctors, a full service eye care center in Tampa and New Port Richey, has announced that they are now providing an innovative new treatment for patients who suffer from dry eye caused by Meibomian Gland Dysfunction (MGD). MGD, a progressive disease that affects some 300 million people worldwide, stems from blockages in the oil-producing meibomian glands located in the eyelids. LipiFlow® unblocks the glands, allowing the glands to resume the secretion of oily lipids needed for a healthy tear film.
Developed as a result of 30 years of scientific research, LipiFlow® is an in-office procedure that uses directed heat and gentle pressure to liquefy and express the contents of meibomian glands. This cutting-edge treatment is FDA-cleared and scientifically proven. In a clinical study, 90 percent of patients achieved improvements in gland secretions after a single LipiFlow® treatment.
MGD can negatively impact long term vision and ocular health. If left untreated, MGD will worsen over time, leading to eye redness, dryness, irritation, burning, and eye fatigue. These symptoms can hinder daily activities such as reading, using the computer, wearing contact lenses, and being outdoors on windy days.
Patients who suffer from these symptoms should be screened for MGD as part of their routine comprehensive eye examination. Early identification of MGD can yield the best results for long term ocular health. LipiFlow® is an FDA-cleared treatment which safely and effectively treats the root cause of disease.
“Dry eye disease is one of the chief complaints that I hear from patients,” said Dr. Samuel Teske, optometrist at The Eye Doctors. “We are pleased to introduce LipiFlow® for our patients who are negatively impacted by MGD. Conventional therapies, such as warm compresses, over-the-counter wetting drops, ointments, and prescription drugs have failed to provide the relief that LipiFlow® offers. LipiFlow® is safe and the most effective treatment for MGD available today. Our patients have reported great improvement with their dry eye over the course of their treatment.”
About The Eye Doctors
The Eye Doctors provides an array of eye care services including comprehensive eye exams for all ages, dry eye treatment, eye disease management, and vision corrective services such as Ortho-K and CRT. Their team of eye care professionals have outstanding credentials to deliver the best care and outcomes for patients. The Eye Doctors utilizes the most advanced technology to deliver the best solutions safely and reliably to their patients.
Residents of the Tampa and New Port Richey communities who would like to schedule an appointment or who have questions regarding LipiFlow® treatments are invited to call The Eye Doctors at (813) 632-2020. For more information on the services and hours at this optometry clinic, visit their website at http://theeyedocs.com/.
The Eye Doctors, (813) 632-2020


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



